A multi-analyte panel for non-invasive pharmacokinetic monitoring of second-line anti-tuberculosis drugs
- 1 July 2016
- journal article
- Published by International Union Against Tuberculosis and Lung Disease in The International Journal of Tuberculosis and Lung Disease
- Vol. 20 (7), 991-992
- https://doi.org/10.5588/ijtld.16.0201
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Moving Beyond Directly Observed Therapy for TuberculosisPLoS Medicine, 2015
- Simple and accurate quantitative analysis of 20 anti-tuberculosis drugs in human plasma using liquid chromatography–electrospray ionization–tandem mass spectrometryJournal of Pharmaceutical and Biomedical Analysis, 2015
- New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospectsThe Lancet Infectious Diseases, 2014
- Method for simultaneous analysis of nine second-line anti-tuberculosis drugs using UPLC-MS/MSJournal of Antimicrobial Chemotherapy, 2013
- Simultaneous determination of first‐line anti‐tuberculosis drugs and their major metabolic ratios by liquid chromatography/tandem mass spectrometryRapid Communications in Mass Spectrometry, 2007